Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of pseudomonas exotoxin

Journal of Urology

Volumn 158, Issue 3, 1997, Pages 948-953

  Maini, Atul ^b   Hillman, G ^b   Haas, Gabriel P ^b   Wang, Ching Y ^b   Montecillo, Emily ^b   Hamzavi, Fasahat ^b   Edson Pontes, J ^b   Leland, Pamela ^b   Pastan, Ira ^b   Debinski, Waldemar ^b   Puri, Raj K ^a  

^a Center for Biologics Evaluation/Res   (United States)

^b NONE

Author keywords

Growth stimulation; IL 13 receptors; IL13 Pseudomonas exotoxin; Prostate carcinoma

Indexed keywords

CELL SURFACE PROTEIN; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; PSEUDOMONAS EXOTOXIN;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; COLONY FORMATION; CYTOTOXICITY; GENE MUTATION; GENE TARGETING; GENE THERAPY; GROWTH STIMULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING;

EID: 17644442258     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64369-6     Document Type: Article

References (25)

1. Sheryl, L. P., Tong, T., Bolden, S. and Wingo, P. A.: Cancer statistics. Ca Cancer J. Clinicians, 65: 5, 1996.
2. Obiri, N. I., Debinski, W., Leonard, W. J. and Puri, R. K.: Receptor for interleukin 13. Interaction with interleukin-4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7,9, and 15. J. Biol. Chem., 270: 8797, 1995.
3. Puri, R. K., Leland, P., Obiri, N. L, Husain, S. R., Kreitman, R.'j., Haas, G. P., Pastan, I. and Debinski, W.: Targeting of IL-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein comprised of interleukin-13 and Pseudomonas exotoxin. Blood, 87: 4333, 1996.
4. Debinski, W., Obiri, N. I., Powers, S. K., Pastan, I. and Puri, R. K.: Human glioma cells overexpress receptors for interleukin-13 and are extremely sensitive to a novel chimeric protein composed of interleukin-13 and Pseudomonas exotoxin. Clin. Cancer Res., 1: 1253, 1995.
5. Debinski, W., Obiri, N. I., Pastan, I. and Puri, R. K.: A novel chimeric protein composed of IL-13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for IL-13 and IL-4 . J. Biol. Chem., 270: 16775, 1995.
6. Minty, A., Chalton, P., Deroq, J. M., Dumont, X., Guillemot, J. C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., Minty, C., Casellas, P., Loison, G., Lupker, J., Shire, D., Ferrara, P. and Caput, D. "Interleukin-13 is a new lymphokine regulating inflammatory and immune responses. Nature, 362: 248, 1993.
7. Mckenzie, A. N. J., Culpepper, J. A., de Waal Malefyt, R., Briers, F., Punnonen, J., Aversa, G., Sato, A., Dang, W., Cocks, B. G., Menon, S., de Vries, J. and Zurowski, G.: Interleukin-13, a T-cell derived cytokine that regulates human monocytes and B-cell function. Proc. Natl. Acad. Sci. U.S.A., 90: 3735, 1993.
8. Zurawski, G. and de Vries, J. E.: Interleukin-13, an interleukin-4 like cytokine that acts on monocytes and B-cells, but not on T-cells. Immunol. Today, 15: 19, 1994.
9. de Waal Malefyt, R., Figdor, C. D., Huijbens, R., Mohan, P. S., Bennet, B., Culpepper, J., Dang, W., Zurowski, G., and de Vries, J. E.: Effects of IL-13 on phenotype, and cytokine production, and cytokine function of human monocytes. Comparison with IL-4 and modulation by IFN-g or IL-10. J. Immunol., 151: 6370, 1990.
10. de Waal Malefyt, R., Figdor, C. G. and de Vries, J. E.: Effects of IL-4 on monocyte functions: comparison to interleukin-13. Res. Immunol., 144: 629, 1993.
11. Cocks, B. G., de Waal Malefyt, R., Gallizi, J. P. and de Vries, J. E.: IL-13 induces proliferation and differentiation of human B-cells activated by the CD 40 ligand. Int. Immunol., 5: 657, 1993.
12. Defrance, T., Carayon, P., Billian, G., Guillemont, J. C., Minty, A., Caput, D. and Ferrara, P.: Interleukin-13 is a B-cell stimulating factor. J. Exp. Med., 179: 1325, 1994.
13. Punnonen, J. and de Vries, J. E.: IL-13 induces proliferation, Ig isotype switching and IgG synthesis by immature fetal B-cells. J. Immunol., 152: 1094, 1994.
14. Aversa, G., Punnonen, J., Cocks, B. G., de Waal Malefyt, R., Vega, F., Surowski, S. M., Zurowski, G. and de Vries, J. E.: An interleukin-4 mutant protein inhibits both IL-4and IL-13 induced human immunoglobulin G4 (IgG4) and Ig E synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med., 178: 2213, 1993.
15. Obiri, N. I., Leland, P., Murata, T., Debinski, W., and Puri, R. K.: The interleukin 13 receptor structure differs on various cell types and may share more than one component with interleukin 4 receptor. J. Immunol., 158: 756, 1997.
16. Pastan, I., Chaudhary, V. K. and FitzGerald, D. J.: Recombinant toxins as novel therapeutic agents. Ann. Rev . Biochem., 61: 331, 1992.
17. Debinski, W., Miner, R., Leland, P., Obiri, N. I. and Puri, R. K.: Receptor for IL-13 does not interact with IL-4 but receptor for IL-4 interacts with IL-13 on human glioma cells. J. Biol. Chem., 271: 22428, 1996.
18. Munson, P. J. and Rodbard, D.: Ligand: a versatile combined approach for characterization of ligand-binding systems. Anal. Biochem., 107: 220, 1980.
19. Renard, N., Duvert, V., Banchereau, J. and Saeland, S.: Interleukin-13 inhibits the proliferation of normal and leukemic human B cell precursors. Blood, 84: 2253, 1994.
20. Obiri, N. I., Husain, S. R, Debinski, W. and Puri, R. K: Interleukin -13 inhibits growth of human renal carcinoma cells independently of the p-140 receptor chain. Clin. Cancer Res., 2: 1743, 1996.
21. Serve, H., Oelman, E., Herweg, A., Oberberg, D., Serve, S., Reufi, B., Mucke, C., Minty, A., Thiel, E. and Berdel, W.: Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin-13. Cancer Res., 56: 3583, 1996.
22. Puri, R. K. and Siegel, J. P.: Interleukin-4 and cancer therapy. Cancer Invest., 11: 473, 1993.
23. Puri, R. K: Structure and function of interleukin 4 and its receptors. In: Cytokines: Interleukins and Their Receptors, edited by Kurzrock, R. and Talpaz, M., pp. 143-185, Kluwer Academic Publishers: Norwell, MA, 1995.
24. Myers, J. N., Yasumura, S., Suminami, Y., Hirabayashi, H., Lin, W.-C., Johnson, J. T., Lotze, M. T. and Whiteside, T. L.: Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin-4. Clin. Cancer Res., 2: 127, 1996.
25. Husain, S. R., Obiri, N. I., Gill, P., Zheng, T., Pastan, I., Debinski, W. and Puri, R. K.: Receptor for interleukin-13 on AIDS-Kaposi's sarcoma serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxic protein. Clin, Cancer Res., 3: 151, 1997.